Peptidomimetic inhibitors of herpes virus ribonucleotide reductase. Correlation between herpes simplex and varicella zoster virus
✍ Scribed by Montse Llinàs-Brunet; Neil Moss; Erika Scouten; Michel Liuzzi; Robert Déziel
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 259 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
✦ Synopsis
Peptidomimetic inhibitors based on the C-terminal sequence of herpes simplex virus (HSV) ribonucleotide reductase (RR) small subunit (R2) also inhibit varicella zoster virus (VZV) RR. There is generally good correlation between the potencies against both HSV and VZV RR. There are, however, two important differences. A urea moiety at the N-terminus improves potency against HSV RR but offers no advantages against VZV RR. y-Methylleucine at the C-terminus is also beneficial for HSV RR but decreases potency considerably for VZV RR.
📜 SIMILAR VOLUMES
The differential diagnosis of herpes simplex and zoster may require virological confirmation, yet virus typing is not regarded as necessary in routine dermatological assessment. In an attempt to evaluate the clinical benefits of the routine detection of herpes simplex virus (HSV) and varicella zoste
Serological responses to varicella-zoster virus (VZV) subunit antigens, such as capsid, envelope, and soluble (S) antigens, in patients with VZV and herpes simplex virus (HSV) infections were studied by comparing with responses to virion (V) antigens using an enzyme-linked immunosorbent assay (ELISA